Author:
Tiek Deanna,Song Xiao,Yu Xiaozhou,Iglesia Rebeca,Wu Runxin,Catezone Alicia,McCourtney Katy,Walshon Jordain,Horbinski Craig,Jamshidi Pouya,Castellani Rudolph,Vassar Robert,Miska Jason,Hu Bo,Cheng Shi-Yuan
Reference64 articles.
1. Protein aggregation and neurodegenerative disease;C A Ross;Nat Med,2004
2. Tau Protein as Therapeutic Target for Cancer?;R Hedna;Focus on Glioblastoma. Cancers (Basel),2022
3. Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial;R Stupp;JAMA,2017
4. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma;R Stupp;The New England journal of medicine,2005
5. Mechanisms of temozolomide resistance in glioblastoma -a comprehensive review;N Singh;Cancer Drug Resist,2021